NewslettersCell Therapy NewsNanobody-Derived Bispecific CAR-T Therapy Enhances Anti-Tumor Efficacy of T Cell Lymphoma TreatmentBy Bob - July 31, 20230205Investigators demonstrated that nanobody-derived bispecific CAR-T cells significantly improved anti-tumor efficacy in T-lymphoma treatment.[Molecular Therapy Oncolytics]AbstractFull ArticleGraphical Abstract